Scarica l'app Stockscreener
4.20
0.94%
-0.04
Pre-mercato:
4.29
0.09
+2.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie
Recursion Pharmaceuticals (NasdaqGS:RXRX) Sees 27% Weekly Drop After Leadership Changes - Yahoo Finance
Long Term Trading Analysis for (RXRX) - news.stocktradersdaily.com
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March - MSN
Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market - Yahoo Finance
Recursion to Participate in Upcoming Investor Conference - Bluefield Daily Telegraph
Recursion stock hits 52-week low at $5.5 amid market challenges - Investing.com Canada
Recursion stock hits 52-week low at $5.5 amid market challenges By Investing.com - Investing.com South Africa
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today - Yahoo Finance
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? - Yahoo
Nvidia Has 81% of Its $304 Million Stock Portfolio Invested in 3 Groundbreaking AI Stocks - The Motley Fool
Recursion Pharmaceuticals CEO sells $836,986 in stock By Investing.com - Investing.com Australia
Recursion Pharmaceuticals CEO sells $836,986 in stock - Investing.com India
Why Recursion Pharmaceuticals Inc. (RXRX) Performed Worst On Tuesday? - MSN
Recursion: A Look At Near-Term Phase 1b And Phase 2 Catalysts (NASDAQ:RXRX) - Seeking Alpha
(RXRX) Investment Report - Stock Traders Daily
Is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit? - Insider Monkey
12 Best AI Stocks to Invest in According to Reddit - Insider Monkey
Why Recursion Pharmaceuticals (RXRX) Went Up on Monday? - MSN
Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today - Yahoo Finance
RXRX Quantitative Stock AnalysisBenjamin Graham - Nasdaq
Recursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity Offering - Yahoo Finance
Recursion Pharma Down 37% in a Month: Buy, Sell or Hold the Stock? - Zacks Investment Research
Recursion Pharmaceuticals Strengthens Board with New Appointments - TipRanks
Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun - Yahoo Finance
These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company
Recursion Pharmaceuticals's Options: A Look at What the Big Money is Thinking - Benzinga
Jones Financial Companies Lllp Has $229,000 Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL
HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer - Business Wire
Proficio Capital Partners LLC Makes New $163,000 Investment in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
Recursion Pharmaceuticals: Stretched Thin And Chasing Unicorns - Seeking Alpha
Jim Cramer on Recursion Pharmaceuticals, Inc. (RXRX): ‘We’re Going To Have To Hold Off’ - Insider Monkey
Recursion Pharma Gets A Price-Target Cut After Q4 Miss: Retail Bearish Even As Cathie Wood's Ark Buys The Dip - MSN
Why Recursion Pharmaceuticals Stock Is Sinking Today - Yahoo Finance
Jim Cramer’s Latest Lightning Round: 8 Stocks in Focus - Insider Monkey
Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy? - Nasdaq
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
QRG Capital Management Inc. Grows Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
This Is What Whales Are Betting On Recursion Pharmaceuticals - Benzinga
Private Advisor Group LLC Increases Stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - Defense World
4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today - MSN
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):